hibergene

Home/Tag: hibergene

Hibergene’s game changing COVID test

Hibergene's newly CE-marked COVID-19 test delivers positive results in approximately 30 minutes and is now available for sale in Ireland and internationally. CE-approval followed the completion of a clinical evaluation study at the Mater Private Hospital, Dublin, Ireland, that has demonstrated the efficacy of the product. The new COVID-19 test, which expands the company’s product range to 13 tests, employs HiberGene’s proprietary molecular reagent format [...]

2020-05-21T10:43:32+00:00May 20th, 2020|Categories: News, Press Release|Tags: , |

Shackleton Team Invests in Hibergene

We are pleased to announce that the Shackleton team has invested in Hibergene Diagnostics.   The company develops, manufactures and markets molecular diagnostic tests for human infectious diseases, using LAMP (Loop Mediated Isothermal Amplification) technology. HiberGene is developing its next generation devices to disrupt the established time-consuming and high skilled testing market.  Its devices offer: Testing at front line medical centres; Real-time, accurate results within [...]

2020-04-22T07:44:18+00:00April 16th, 2020|Categories: Funding, News, Uncategorized|Tags: , , |